BiochemistrybioRxivPreprint
Fortuitous in vitro compound degradation produces a tractable hit against Mycobacterium tuberculosis dethiobiotin synthetase: a cautionary tale of what goes in, does not always come out
W. Salaemae, A. P. Thompson, B. I. Gaiser…·K. L. Wegener
The paper describes how a fragment compound was inadvertently modified in crystal conditions, leading to a potent inhibitor of Mycobacterium tuberculosis dethiobiotin synthetase.
DOI 10.1101/2023.03.26.531482